investor
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good News! Great News!
Patients 2 and 3 improving and pps moving up nicely.
NVIV continues on roll. How far will the pps rise today?
$18, $19, $20 and above?
So the fact that NVIV is up 235% in the last year, and that some investors might be looking to take some profits, surprises you?
Vs. the Nasdaq that is up 12.5% in the last year.
Unless we have negative news, the pps only goes higher from here.
Do you own any NVIV? or are you just looking for an entire point?
My suggestion is to buy if NVIV's pps gets anywhere near $14.75.
So we have predicted $2-$3 pps, but definitely a $1.00.
Then predicted $.30's but definitely $.40 by the end of last week.
So this week I'm looking for anywhere between $.30's and $3.00 pps.
I think we have a good shot at getting it right with that prediction.
Thanks for your help with the direction of RXII pps.
The shorts aren't going away yet.
They will try to pull this down on a regular basis.
Looks like RXII is trying to establish a base today in the $.56-$.57 area.
Higher highs and higher lows. A good thing!
Looks like 3 million shares trade in the 1st hour.
1. Someone wants in bad
2. Someone is adding at these bargain levels
3. Short covering
Headed toward 2 million share traded in the 1st 30 minutes.
HUGE volume.
Looking for $.60.
We have $.60. UP 14% this AM.
Keep it rolling!
Over 800k shares traded in the 1st 15 minutes and busting through walls of shares up to $.57+. We have 24k shares on the ask at $.58. Can we take that down?
I guess we can, as I type all 24K bought.
Looks strong today. Looking for that $1.00 pps, in the near future and then moving higher.
PPS up 2% and all we get on the board is a Yawn?
No news for a couple of days and they've tried to take the pps down, but it holds and the finishes higher at the EOD.
With many catalysts upcoming, NVIV is going higher, much higher.
They try to paint the close almost every day, down a cent or two.
I look for continued pressure and maybe even a bear raid by the shorts. But I'm looking to buy the dips and I feel we are on a march to $1.00 and above.
Higher highs and higher lows, a very good sign.
I have been following NVIV since the pps was $6 presplit on just pump and potential.
Followed it back to $.50 and watched it built back up by new management and the results of the pilot study.
We longs, imho, should see this great run continue. My target was a pps of at least $20 by year end, but we may see that in the next few months.
This is great for us, but most importantly, I feel NVIV offers great hope to those with SCI.
To continued success!
Flat day, I guess no one has anything to say.
Sellers tried to take the pps down, but enough buyers around to keep us even for the day. I think that is a very good sign.
Find a base around $15 and wait for the new patients and updates on all those currently enrolled.
I'm looking for substantial movement, to the positive, in the coming months.
RXII up 30% off the low. Didn't think it was going to continue straight up.
Given the recent history, of the pps, I think RXII held up very well to the shorts and the profit takers today.
I'm continuing to hold tight looking for more upside in the coming months. JMHO.
Some block sellers, but all shares being gobbled up as we move a reaching higher pps.
Volume has been up over the last week.
Today surpassed the Average volume for the day in less than an hour.
There are buyers out there at these bargain prices.
Currently riding a wave of upside pressure.
Looks like RXII is starting higher this AM.
IMO we will see a close over $.40 pps and today is the start of a long uptrend in the pps.
Less selling pressure and positive news moving the pps higher through out 2015.
Surprised there wasn't a tweet about the upcoming offering.
Well said!
We often take for granted the freedoms we are guaranteed, and those that help maintain them.
Be ever vigilant to guard the freedom and liberty we enjoy, and support those who do it actively, in our military.
Looking forward to continuing our Friday momentum. Go CTIX
I can't tell you what the other Longs are doing, but I'm holding my shares and waiting for the next, of many, catalysts to occur.
I have also added a substantial amount to my NVIV holdings over the last 3 weeks. Felt it was the prudent thing to do, give the sale prices we've been having.
I think we would consider the improvement that Jordan has had since the scaffold was implanted to be "great". I would also consider Jesi's improvement, while not as great as Jordan's, to be a very positive sign.
Wouldn't you?
Shares on Sale today.
Bought more and will look to do so again tomorrow.
As Hound said, during the time between the RS and the enrollment of patients 3-5, and the uplist, you could see some buying opportunities. Not that we couldn't see patients enrolled this week.
I was please, however, that this was a 5% up day. Low volume today could have meant that we had some investors taking a wait as see approach to the RS before adding or jumping in.
The buying could resume at anytime, and that is the investors dilemma.
Buying the dips.
Purchased more shares today @ $2.83
Current Average pps: $1.39
Tried to find the bottom of the dip and had an order at $2.61, and some trades executed there, unfortunately, not mine.
Not too bad, 6% drop mid-day, and I really don't like RS, but so much positive news recently and upcoming, I still think NVIV is a strong buy.
Still could see some volatility in the PPS, but in the long term this path might be the best for the company and the shareholders.
Pretty common, over the last year, that shorty comes out on the days when the company updates the clinical trial program.
I have come to expect it and look to add to my position. Nothing negative or surprising in the information released today. Over the past two weeks, RXII's volume has been increasing, and I have taken that as a positive moving forward.
I think that both the Hypertrophic Dermal Scars trial, and RXI-109 Treatment to Reduce the Formation of Keloids Following Keloidectomy trial will and have been positive.
I have held RXII for a few years and will continue to hold as these trials continue to show positive results.
No reason for the pps drop today. Stock is being manipulated so someone can accumulate shares closer to $1.00.
I continue to add as these levels, especially when I see nothing negative to cause this temporary drop in price.
Pretty hard to figure the price action of RXII this past week.
30% swings in price on two days on heavy volume.
Most of us feel there is value here. Someone is buying shares as the price moves from $1.30 to 1.73 and from $1.08 to $1.48 today.
Unfortunately we have seen a quick reversal from these intraday highs.
Do we have day trading, shorts jumping on the stock after these run ups, or do we have accumulation while others profit-take on the runs?
Sheff decided to take his 25% profit and move on at $2.50 today.
Don't know how many of his followers will do the same, but it looks like his position was small and his exit did not seem to have a negative effect on pps.
Onward and Upward.
I never saw any news or "pump" that moved the price up.
Was nice while it lasted. Someone was buying.
I think we might see some positive news in the near future.
I am holding still for more than the $1.70 of this week.
Absolutely no fundamental reason for this pullback. Limited news recently leading to some downward pressure/profit taking on the pps.
May be a technical pullback/buying opportunity, as some have said. The pps should rebound with upcoming news. I'm adding to my position today from an average of $1.20 pps.
Another day with good volume and pps pushing higher.
Hopefully this is some accumulation before positive news.
Good Volume today.
Hopefully news in the near future about one of the three phase 2 trials.
Wow! wiped out that 10K block at $2.96 just like that!
We've seen some profit takers, which can be expected, but the PPS has held up very well today, after the run toward $3.00.
Not selling a share at this level. Expecting this run to continue with all the news and catalysts due in the near future.
Pretty dismal chart. Looking for support levels from 2013?
Anything that could possibly move this right direction?
Well FB members, why is this a buy, even at these levels?
Decent volume today compared to the last few months. I guess there are some, like me, that look back nostalgically at the catalysts and the pps movement of 2013. Maybe their looking for bargains.
I dipped my toe in here, but without any catalysts, I think you might be right and we have yet to find that bottom.
Everything seemed to being going so right, and many believed that Dr. Kim could do no wrong. The results of 2014 show that the market did not like the direction Dr. Kim was leading INO. Dr. Kim may prove many of us wrong, but it looks like it may take much more time than many investors are willing to wait.
I think INO is still on the radar of some investors, but I think most are taking a wait and see approach to the stock. Dr. Kim is going to have to prove he can add value to the company before many investors return.
Plenty of value here with phase 2 trials underway, if your willing to be patient.
I'm in for the long haul and will be buying on the dips.
Been on Sheff's board over two years. He can drive a pps up over the short term, but often takes profit of, as little as 10%, and usually does not hold a stock long term.
I on the other hand am a long term investor here, but I will not be surprised if we see some short term trading by some shareholders here. Of course that means some short term volatility in the pps.
Company's Chief Development Officer, Dr. Pamela Pavco, will present at the 17th Annual BIO CEO & Investor Conference on Monday, February 9, 2015 at 9:00 a.m. EST in New York City. Dr. Pavco will provide an update on the Company's Dermatology and Ophthalmology Franchises.
www.rxipharma.com.
Volume returning today, especially early, prior to the above investor conference. Looks like some are expecting positive news.
Holding tight my investment here and will continue to add on any dip.
Sounds like a plan. I also maybe looking for an entry point here.